Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
2.110
+0.070 (3.43%)
At close: Nov 21, 2024, 4:00 PM
2.102
-0.008 (-0.39%)
After-hours: Nov 21, 2024, 5:46 PM EST

Immuneering Stock Forecast

IMRX's stock price has decreased by -62.19% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 5 analysts with 12-month price forecasts for Immuneering stock have an average target of 12.8, with a low estimate of 3.00 and a high estimate of 25. The average target predicts an increase of 506.64% from the current stock price of 2.11.

Analyst Consensus: Buy
Target Low Average Median High
Price $3.00 $12.8 $13 $25
Change +42.18% +506.64% +516.11% +1084.8%

Analyst Ratings

The average analyst rating for Immuneering stock from 7 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Jun '24Jul '24Aug '24Sep '24Oct '24Nov '24
Strong Buy 333333
Buy 222111
Hold 443333
Sell 000000
Strong Sell 000000
Total 998777

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Chardan Capital
Chardan Capital
Strong Buy
Maintains
$13
Strong Buy Maintains $13 +516.11% Nov 20, 2024
Needham
Needham
Strong Buy
Reiterates
$15
Strong Buy Reiterates $15 +610.90% Nov 14, 2024
Needham
Needham
Strong Buy
Reiterates
$15
Strong Buy Reiterates $15 +610.90% Sep 13, 2024
Chardan Capital
Chardan Capital
Strong Buy
Maintains
$16$12
Strong Buy Maintains $16$12 +468.72% Aug 7, 2024
Needham
Needham
Strong Buy
Reiterates
$15
Strong Buy Reiterates $15 +610.90% Aug 7, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.92
from -1.88
EPS Next Year
-1.68
from -1.92
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
1.92M2.31M2.08M316.95K----
Revenue Growth
-20.41%-10.02%-84.76%----
EPS
-1.56-3.44-2.46-1.91-1.88-1.92-1.68-1.95
EPS Growth
--------
Forward PE
--------
No. Analysts -----997
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High n/a n/a n/a
Avg n/a n/a n/a
Low n/a n/a n/a

Revenue Growth

Revenue Growth 20242025202620272028
High - - -
Avg - - -
Low - - -

EPS Forecast

EPS 20242025202620272028
High -1.66 -0.79 -0.88
Avg -1.92 -1.68 -1.95
Low -2.14 -2.37 -2.61

EPS Growth

EPS Growth 20242025202620272028
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.